Stockscreener 앱 받기
7.07
0.56%
-0.04
전일 마감가:
$7.11
열려 있는:
$7.16
하루 거래량:
74,759
Relative Volume:
0.61
시가총액:
$47.95M
수익:
-
순이익/손실:
$-74.14M
주가수익비율:
-0.6207
EPS:
-11.39
순현금흐름:
$-65.70M
1주 성능:
-0.84%
1개월 성능:
-37.16%
6개월 성능:
-72.47%
1년 성능:
-66.99%
1일 변동 폭
$7.02
$7.36
1주일 범위
$6.91
$7.36
52주 변동 폭
$5.67
$42.79
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
TIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
7.07 | 48.22M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - Your Wyoming Link
(TIL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Forecast Cut: Can Instil Bio Inc scale operations efficientlyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - GlobeNewswire Inc.
Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock see PE expansionJuly 2025 Drop Watch & Fast Entry Momentum Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock benefit from green energy trendsMarket Risk Summary & Community Supported Trade Ideas - Улправда
Portfolio Update: Is Instil Bio Inc. stock a good choice for value investorsJuly 2025 Opening Moves & Daily Volume Surge Signals - Улправда
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com South Africa
Why analysts remain bullish on Instil Bio Inc. stockMarket Entry Points & Low Risk Trading Portfolio - Улправда
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Australia
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Nigeria
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M By Investing.com - Investing.com South Africa
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil’s bispecific dream is over | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
(TIL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
IPO Launch: How Zura Bio Limited stock valuations compare to rivalsNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Insider Buy: How Instil Bio Inc stock performs after earningsChart Signals & Short-Term Trading Alerts - moha.gov.vn
Rally Mode: Why Instil Bio Inc. stock is favored by top institutionsJuly 2025 Review & High Accuracy Trade Alerts - Улправда
What Wall Street predicts for Instil Bio Inc. stock price2025 Sector Review & Breakout Confirmation Alerts - Улправда
Aug Catalysts: Will Instil Bio Inc. stock outperform Dow Jones indexQuarterly Market Summary & Free Verified High Yield Trade Plans - DonanımHaber
Analyst Downgrade: Is Instil Bio Inc. stock a good choice for value investors2025 Price Action Summary & Weekly Sector Rotation Insights - Улправда
Is Instil Bio Inc. stock attractive for hedge fundsMarket Activity Report & AI Enhanced Trade Execution Alerts - DonanımHaber
Instil Bio Earnings Notes - Trefis
(TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Check out Instil Bio's stock price (5GT0-FF) in real time - CNBC
Is Instil Bio Inc a good long term investmentInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Responsive Playbooks and the TIL Inflection - news.stocktradersdaily.com
Instil Bio Inc (TIL) looking to reclaim success with recent performance - Setenews
Operating income of Instil Bio, Inc. – FWB:5GT0 - TradingView
Understanding the Setup: (TIL) and Scalable Risk - news.stocktradersdaily.com
Why Instil Bio Inc. stock is a value investor pickMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Is Instil Bio Inc. showing signs of accumulation2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인스틸 바이오 주식 (TIL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
4.73%
0.92%
자본화:
|
볼륨(24시간):